Parkwood LLC’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,286
Closed -$201K 179
2017
Q4
$201K Buy
+1,286
New +$202K 0.03% 232
2017
Q3
Sell
-1,992
Closed -$322K 299
2017
Q2
$322K Buy
+1,992
New +$323K 0.05% 270
2016
Q4
Sell
-9,190
Closed -$1.04M 524
2016
Q3
$1.04M Sell
9,190
-40,697
-82% -$4.29M 0.15% 114
2016
Q2
$4.63M Sell
49,887
-2,435
-5% -$209K 0.77% 24
2016
Q1
$4.1M Sell
52,322
-19,178
-27% -$1.38M 0.69% 25
2015
Q4
$5.21M Buy
+71,500
New +$5.1M 0.82% 17
2015
Q1
Sell
-3,646
Closed -$270K 531
2014
Q4
$270K Buy
+3,646
New +$256K 0.04% 387
2014
Q1
Sell
-3,562
Closed -$189K 294
2013
Q4
$189K Buy
+3,562
New +$187K 0.05% 209

Other funds holding IDXX

Parkwood LLC's IDXX Position: Q1 2018 in Review

Parkwood LLC sold out of Idexx Laboratories (IDXX) in Q1 2018, closing a stake of 1,286 shares — an estimated $201K sold.

Parkwood LLC first reported a position in IDXX in Q4 2013 and held it in 8 quarters. The position peaked at $5.21M in Q4 2015. 646 funds tracked by Wall St. Rank hold IDXX as of Q1 2018.

  • Parkwood LLC reported no remaining Idexx Laboratories position as of Q1 2018 after selling out during the quarter.
  • Parkwood LLC sold 1,286 Idexx Laboratories shares in Q1 2018, an estimated $201K.
  • Parkwood LLC first reported a position in Idexx Laboratories in Q4 2013 and held it in 8 quarters.
  • Parkwood LLC's Idexx Laboratories position peaked at $5.21M in Q4 2015.
  • 646 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2018.

Based on Parkwood LLC's 13F filing for Q1 2018, filed 24 Apr 2018.